ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease

World Journal of Gastroenterology

Volumn 16, Issue 37, 2010, Pages 4685-4690

  Jaime, Sánchez Cuén ^a   Maribel, Aguilar Medina ^b   Eliakym, Arámbula Meraz ^b   José, Romero Navarro ^b   Julio, Granados ^c   Laura, Sicairos Medina ^b   Rosalío, Ramos Payán ^b  

^a ISSSTE Hospital   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Apolipoprotein; CYP7A1; Gallstones; Mexicans; Polymorphisms

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN E; CHOLESTEROL 7ALPHA MONOOXYGENASE;

ADULT; ARTICLE; CHOLELITHIASIS; CHOLESTEROL STONE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 77957843085     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i37.4685     Document Type: Article

References (45)

1. Everhart JE. Gallstones and ethnicity in the Americas. J As-soc Acad Minor Phys 2001; 12: 137-143
2. Méndez Sánchez N, Uribe Esquivel M, Jessurun Solomou J, Cervera Ceballos E, Bosques Padilla F. [Epidemiology of gallstone disease in Mexico] Rev Invest Clin 1990; 42 Suppl: 48-52
3. Marschall HU, Einarsson C. Gallstone disease. J Intern Med 2007; 261: 529-542
4. Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 423-433
5. Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007; 27: 109-121
6. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006; 368: 230-239
7. Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodríguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11: 1653-1657
8. Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005; 71: 97-105
9. Puppala S, Dodd GD, Fowler S, Arya R, Schneider J, Farook VS, Granato R, Dyer TD, Almasy L, Jenkinson CP, Diehl AK, Stern MP, Blangero J, Duggirala R. A genome wide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006; 78: 377-392
10. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichten-stein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005; 41: 1138-1143
11. Duggirala R, Mitchell BD, Blangero J, Stern MP. Genetic determinants of variation in gallbladder disease in the Mexican-American population. Genet Epidemiol 1999; 16: 191-204
12. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002; 110: 109-117
13. Mohr GC, Kritz-Silverstein D, Barrett-Connor E. Plasma lipids and gallbladder disease. Am J Epidemiol 1991; 134: 78-85
14. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99: 843-849
15. Buch S, Schafmayer C, Völzke H, Becker C, Franke A, von Eller-Eberstein H, Kluck C, Bässmann I, Brosch M, Lammert F, Miquel JF, Nervi F, Wittig M, Rosskopf D, Timm B, Höll C, Seeger M, ElSharawy A, Lu T, Egberts J, Fändrich F, Fölsch UR, Krawczak M, Schreiber S, Nürnberg P, Tepel J, Hampe J. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007; 39: 995-999
16. van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, Berger R, Houwen RH, Klomp LW. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127: 379-384
17. Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003; 125: 452-459
18. Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LH, Humphries SE, Kesäniemi YA. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995; 36: 804-812
19. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630
20. Brown MS, Goldstein JL. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest 1983; 72: 743-747
21. Gajra B, Candlish JK, Saha N, Heng CK, Soemantri AG, Tay JS. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population. Genet Epidemiol 1994; 11: 19-27
22. Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH. Classification and nomenclature of gallstones revisited. Yonsei Med J 2003; 44: 561-570
23. Kenny AP. The determination of cholesterol by the Lieber-mann-Burchard reaction. Biochem J 1952; 52: 611-619
24. Gustincich S, Manfoletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11: 298-300+302
25. Priestley L, Knott T, Wallis S, Powell L, Pease R, Brunt H, Scott J. RFLP for the human apolipoprotein B gene: V;XbaI. Nucleic Acids Res 1985; 13: 6793
26. Hixson JE, Vernier DT. Restriction isotyping of human apo-lipoprotein E by gene amplifcation and cleavage with HhaI. J Lipid Res 1990; 31: 545-548
27. Jiang ZY, Han TQ, Suo GJ, Feng DX, Chen S, Cai XX, Jiang ZH, Shang J, Zhang Y, Jiang Y, Zhang SD. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol 2004; 10: 1508-1512
28. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Rodríguez-Pérez JM, Zuñiga J, Granados J. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett 2004; 95: 31-35
29. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-253
30. Sun H, Tang H, Jiang S, Zeng L, Chen EQ, Zhou TY, Wang YJ. Gender and metabolic differences of gallstone diseases. World J Gastroenterol 2009; 15: 1886-1891
31. Petitti DB, Friedman GD, Klatsky AL. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med 1981; 304: 1396-1398
32. Morán S, Duque-López MX, Salmerón-Castro J, Rodríguez-Leal G, Martínez-Salgado H, Uribe M. Association between serum concentration of apolipoproteins A-I and B with gallbladder disease. Arch Med Res 2003; 34: 194-199
33. Han T, Jiang Z, Suo G, Zhang S. Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease. Clin Genet 2000; 57: 304-308
34. Kurzawski M, Juzyszyn Z, Modrzejewski A, Pawlik A, Wiatr M, Czerny B, Adamcewicz R, Droździk M. Apolipo-protein B (APOB) gene polymorphism in patients with gallbladder disease. Arch Med Res 2007; 38: 360-363
35. Singh MK, Pandey UB, Ghoshal UC, Srivenu I, Kapoor VK, Choudhuri G, Mittal B. Apolipoprotein B-100 XbaI gene polymorphism in gallbladder cancer. Hum Genet 2004; 114: 280-283
36. Gamboa R, Hernandez-Pacheco G, Hesiquio R, Zuñiga J, Massó F, Montaño LF, Ramos-Kuri M, Estrada J, Granados J, Vargas-Alarcón G. Apolipoprotein E polymorphism in the Indian and Mestizo populations of Mexico. Hum Biol 2000; 72: 975-981
37. Juvonen T, Kervinen K, Kairaluoma MI, Lajunen LH, Kesäni-emi YA. Gallstone cholesterol content is related to apolipo protein E polymorphism. Gastroenterology 1993; 104: 1806-1813
38. Bertomeu A, Ros E, Zambón D, Vela M, Pérez-Ayuso RM, Targarona E, Trías M, Sanllehy C, Casals E, Ribó JM. Apoli-poprotein E polymorphism and gallstones. Gastroenterology 1996; 111: 1603-1610
39. Mella JG, Schirin-Sokhan R, Rigotti A, Pimentel F, Villar-roel L, Wasmuth HE, Sauerbruch T, Nervi F, Lammert F, Miquel JF. Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations. J Lipid Res 2007; 48: 1378-1385
40. Lin QY, Du JP, Zhang MY, Yao YG, Li L, Cheng NS, Yan LN, Xiao LJ. Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cho-lecystolithiasis. World J Gastroenterol 1999; 5: 228-230
41. Dixit M, Choudhuri G, Saxena R, Mittal B. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease. Can J Gastroenterol 2007; 21: 569-575
42. Hasegawa K, Terada S, Kubota K, Itakura H, Imamura H, Ohnishi S, Aoki T, Ijichi M, Saiura A, Makuuchi M. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone. Am J Gastroen-terol 2003; 98: 1605-1609
43. Fischer S, Dolu MH, Zündt B, Meyer G, Geisler S, Jüngst D. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile. Eur J Clin Invest 2001; 31: 789-795
44. Ko CW, Beresford SA, Alderman B, Jarvik GP, Schulte SJ, Calhoun B, Tsuchida AM, Koepsell TD, Lee SP. Apolipo-protein E genotype and the risk of gallbladder disease in pregnancy. Hepatology 2000; 31: 18-23
45. Barquera R, Zúñiga J, Hernández-Díaz R, Acuña-Alonzo V, Montoya-Gama K, Moscoso J, Torres-García D, García-Salas C, Silva B, Cruz-Robles D, Arnaiz-Villena A, Vargas-Alarcón G, Granados J. HLA class I and class II haplotypes in admixed families from several regions of Mexico. Mol Immunol 2008; 45: 1171-1178